Macron says all French people will be offered vaccine by end of summer

PARIS (Reuters) – French President Emmanuel Macron said on Tuesday all French people who are willing to be vaccinated against COVID-19 will be offered a vaccine by the end of summer.

FILE PHOTO: French President Emmanuel Macron puts on his protective face mask as he delivers a statement with Serbian President Aleksandar Vucic (not seen) at the Elysee Palace in Paris, France, February 1, 2021. REUTERS/Benoit Tessier

In an interview with TF1 television, Macron also said that because the virus is evolving quickly, pharmaceutical companies need to start preparing now for vaccines that will be needed this winter and early next year.

He said that in the coming weeks, by the end of February through early March, production of COVID-19 vaccines in France will start and there would eventually be four different production centres.

He further said vaccines must be supplied to poorer developing countries, notably Africa and Latin America.

“We must think about developing countries because if we do not vaccinate there too, the virus will circulate there and mutate, and it will strike unjustly the poorest people, and then the virus will come back to our countries.”

Macron said the major constraint today was not intellectual property but production capacity and that companies who invented the vaccines must link up with those who can help them boost output, while respecting intellectual property rights.

” We are now converting sites in Europe to produce vaccines. Sanofi will convert a site in Germany in coming months to produce (COVID-19 vaccines),” he said.

He added that the 27-nation European Union so far had ordered a supply of about 2.4 billion vaccines. Some EU member states have sharply criticised the slow rollout of vaccination programmes within the bloc.

Asked about Russia’s Sputnik V vaccine, Macron said that a few weeks ago he had sent a scientific mission to Russia and the exchanges were positive, and that there had been reports indicating the shot was effective against COVID-19.

“But in order to approve a vaccine, a request to market it must first be made. The minute a request is made, European and national authorities will study this independently and, depending on the results, approve it or not. It is not a political decision but a scientific decision,” he said.

Source: Read Full Article